Molecular pathology in the context of personalised cancer medicine

Speaker: Ian Cree

Ian Cree discusses how Genomics improve the management of patients with cancer, importance of interactions between different members of the management team in the analysis and interpretation of genomic study results, assessment of clinical validity and clinical utility of genomic variants and technologies; he provides critical appraisals of new genomic technologies in oncology and future perspective of molecular pathology technologies application in the oncology practice.

Discussion Points

  1. Please can you provide a snapshot of how Genomics is currently improving the management of patients with cancer.
  2. What is the importance of interactions between different members of the management team in analysing and interpreting genomic study results?
  3. Why is it important to assess the validity and utility of genomic variants and technologies?
  4. Please can you provide a brief summary of some of the new genomic technologies in oncology?
  5. What do you think are the future applications of molecular pathology technologies in clinical practice?